From March 10, 2022 to June 10, 2022, the company has repurchased 519,451 shares, representing 1.01% for KRW 10,000.02 million. With this, the company has completed the repurchase of 519,451 shares, representing 1.01% for KRW 10,000.02 million under the buyback announced on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36,700 KRW | -2.39% | +4.41% | -17.16% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.16% | 1.36B | |
+37.74% | 723B | |
+34.85% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+16.42% | 244B | |
+9.77% | 208B | |
-4.54% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- A009420 Stock
- News Hanall Biopharma Co., Ltd.
- Tranche Update on Hanall Biopharma Co.,Ltd's Equity Buyback Plan announced on March 10, 2022.